<DOC>
	<DOCNO>NCT02537769</DOCNO>
	<brief_summary>The use implantable leave ventricular assist device ( LVAD ) increase last decade ; partly newer continuous flow pump feature small design well durability . These pump show improved outcome patient n't qualify heart transplantation receive LVAD device permanent therapy bridge heart transplantation . Despite improved outcome , procedure relate length hospitalization LVAD implantation still 2 3 time heart surgery treatment . One important reason many people experience right ventricular dysfunction LVAD implantation . Treatment option limit . Many LVAD patient right ventricular dysfunction also tricuspid valve regurgitation ( TR ) . This failure tricuspid valve ( TV ) close completely blood leak backwards . Some recent study suggest correction TV LVAD implantation improve survival severe regurgitation . However , evaluate mild moderate regurgitation . The goal study look clinical impact surgical correction mild moderate TR participant also undergo LVAD implantation . The study look degree TR various time point post-surgery , well major cardiac adverse event , duration hospitalization , quality life . The investigator hope show surgical correction mild moderate TR LVAD patient reduce right ventricular dysfunction positive impact health outcome .</brief_summary>
	<brief_title>Study Clinical Impact Surgical Correction Tricuspid Insufficiency Implantable LVAD Patients</brief_title>
	<detailed_description>Participant recruitment : At University Washington Medical Center , 30 40 patient mild tricuspid valve regurgitation ( TR ) receive LVAD placement annually . A predict 50 - 60 % patient agree enrol study , estimation 15 20 participant year . With enrollment period 2 year , study aim enroll 30 40 participant Study intervention Specific Techniques : Prior screen data collection protocol define procedure , participant must sign consent form . Within 30 day prior randomization ( part routine clinical care ) , complete transthoracic echocardiogram perform , evaluate , report . Within 7 day prior randomization ( part routine clinical care ) : 1 ) medical history physical exam perform ; 2 ) New York Heart Association ( NYHA ) Canadian Cardiovascular Society ( CCS ) Classes establish document ; 3 ) current medication therapy record study document ; 4 ) participant complete Duke Activity Status Index quality care ( QOL ) assessment . Randomization : Randomization procedure perform intra-operatively , follow sternotomy cannulation aorta . Randomization follow computer generate simple randomization process . Participants randomize equal probability receive LVAD implantation alone LVAD implantation plus surgical repair tricuspid valve ( TV ) . The nature treatments precludes mask participant treat clinician treatment assignment . Surgical technique : Participants randomly assign receive tricuspid valve repair ( TVR ) addition LVAD implantation undergo repair standard technique . After bicaval cannulation heart beating , right atriotomy create TV expose . A patent foramen ovale ( PFO ) , present , close primarily . 2-0 braided suture place radially tricuspid annulus lateral fibrous trigone counterclockwise medial fibrous trigone , thus avoid conduction system . An incomplete semi-rigid annuloplasty ring suspend appropriate sizing . Any ventricular pacing lead mobilize leaflet subvalvular adhesion place commissure septal posterior leaflet . The septal posterior leaflet approximate junction rough smooth zone back lead , bicuspidizing valve , trap ventricular lead away tricuspid valve orifice . Tricuspid valve assessment : The 3 leaflet TV assess echocardiography . The midesophageal inflow-outflow view midesophageal modify bicaval TV view choose Doppler interrogation transvalvular flow . 3D examination also assess . 3D Transesophageal echocardiography ( TEE ) permit precise description elliptical shape TV annulus dimension clinically feasible fashion . Assessment TR severity include several echocardiographic parameter right ventricle ( RV ) , right atrium , inferior vena cava size , area regurgitant jet , width vena contracta ( VC ) , proximal isovelocity surface area , TR jet density contour , well hepatic vein flow pattern . The VC surrogate measurement effective regurgitant orifice area ( EROA ) . Using sequential crop technique keep crop plane precisely parallel TV orifice , vena contracta area ( VCA ) TR jet obtain 3D TEE assessment . Right ventricular function : RV diastolic function assess use pulsed-wave Doppler interrogation tricuspid valve , pulmonary hepatic venous flow rate , well examination tricuspid annulus use tissue Doppler necessary . With , investigator measure tricuspid annular plane systolic excursion ( TAPSE ) , Tei index . The Tei index right ventricular index myocardial performance ( RIMP ) define sum isovolumetric contraction relaxation interval divide ejection time indicator systolic diastolic RV dysfunction . With transthoracic echocardiography ( TTE ) , RIMP &gt; 0.40 pulsed Doppler &gt; 0.55 tissue Doppler suggest RV dysfunction . The investigator also measure tricuspid annular velocity use intraoperative TEE . The tissue Doppler derive tricuspid lateral annular systolic velocity ( S ' ) alternative parameter ass RV function , show correlate well measure global RV systolic function . S ' velocity &lt; 10 cm/s indicate RV systolic dysfunction.The last measurement RV function rise RV right atrial pressure gradient systole ( dP/dT ) . The correlation RV dP/dT TAPSE RV ejection fraction represent another estimate global RV function easily determine use Doppler echocardiography . Perioperative management : A variety strategy may utilize optimize postoperative ventricular function . These strategy may include pacing , infusion vasopressor positive inotropic agent include beta receptor agonists and/or phosphodiesterase inhibitor milrinone . Occasional participant may require additional mechanical support , either intra-aortic balloon pump right ventricular assist device , Extracorporeal Life Support ( ECLS ) .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Tricuspid Valve Insufficiency</mesh_term>
	<criteria>1 . Participant legal representative sign informed consent 2 . Over 18 year age 3 . Participant advance heart failure symptom ( Class III IV ) preoperative mild tricuspid regurgitation schedule implantable LVAD 1 . Prior tricuspid valve repair 2 . Any evidence structural ( chordal leaflet ) tricuspid valve disease 3 . Technical obstacle , pose inordinately high surgical risk , judgment investigator 4 . Existence ongoing mechanical circulatory support intraaortic balloon counter pulsation 5 . Body Mass Index ( BMI ) &gt; 45 6 . Pregnancy 7 . Presence mechanical aortic valve convert bioprosthesis time LVAD implant 8 . History cardiac transplant cardiomyoplasty 9 . Psychiatric disease , irreversible cognitive dysfunction psychosocial issue likely impair compliance study protocol LVAD management 10 . Presence active , uncontrolled infection 11 . Evidence intrinsic hepatic disease define liver enzyme value 12 . History stroke within 90 day prior enrollment , history cerebral vascular disease significant ( &gt; 80 % ) extra cranial stenosis 13 . Need chronic renal replacement therapy ( e.g . chronic dialysis ) 14 . Participation clinical investigation likely confound study result affect study outcome 15 . Any condition , heart failure , could limit survival le 1 year 16 . Participant refuse enrol study 17 . Institution inmate .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>LVAD</keyword>
	<keyword>Tricuspid regurgitation</keyword>
	<keyword>Heart failure</keyword>
	<keyword>Transplant</keyword>
	<keyword>3D transesophageal echocardiography ( TEE )</keyword>
	<keyword>2D transesophageal echocardiography ( TEE )</keyword>
	<keyword>Mild</keyword>
	<keyword>Moderate</keyword>
</DOC>